4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · IEX Real-Time Price · USD
25.34
-0.30 (-1.17%)
At close: May 17, 2024, 4:00 PM
24.72
-0.62 (-2.45%)
After-hours: May 17, 2024, 7:37 PM EDT

4D Molecular Therapeutics Revenue

4D Molecular Therapeutics had revenue of $20.45M in the twelve months ending March 31, 2024, with 826.69% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $28.00K, a -90.60% decrease year-over-year. In the year 2023, 4D Molecular Therapeutics had annual revenue of $20.72M with 562.29% growth.

Revenue (ttm)
$20.45M
Revenue Growth
+826.69%
P/S Ratio
64.06
Revenue / Employee
$139,129
Employees
147
Market Cap
1.31B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202320.72M17.59M562.29%
Dec 31, 20223.13M-14.91M-82.65%
Dec 31, 202118.04M4.43M32.52%
Dec 31, 202013.61M6.63M94.85%
Dec 31, 20196.99M-7.14M-50.56%
Dec 31, 201814.13M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition